Parnax Lab share price
High risk
You have to be logged in to add this to Watchlist.- ₹103.00(-0.48%)June 30, 2025 15:15:00 PM IST
- NSE
- BSE
- Vol : 2.08K (NSE + BSE)Last 20 day avg : 3.37 K
Parnax Lab is trading -0.48% lower at Rs 103.00 as compared to its last closing price. Parnax Lab has been trading in the price range of 103.50 & 103.00. Parnax Lab has given -38.39% in this year & 2.83% in the last 5 days. Parnax Lab has TTM P/E ratio 10.65 as compared to the sector P/E of 22.85.The company posted a net profit of 2.92 Crores in its last quarter.Listed peers of Parnax Lab include Mangalam Drugs And Organics (0.22%), Take Solutions (4.91%), Parnax Lab (-0.48%).The Mutual Fund holding in Parnax Lab was at -% in . The MF holding has - from the last quarter. The FII holding in Parnax Lab was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Jun 30, 2025, 12:20 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values1.43The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values10.30Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility0.99Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.84The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Parnax Lab Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 5.76% from Rs 49.04 crore to Rs 46.37 crore, year-on-year
- The company has grown its March quarter profit by 30.28% from Rs 2.24 crore to Rs 2.92 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
Parnax Lab Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 115.06
- R2
- 121.76
- R3
- 129.76
Pivot107.06
- S1
- 100.36
- S2
- 92.36
- S3
- 85.66
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Parnax Lab Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Mangalam Drugs And Organics | Moderately Bearish | 80.87 | 0.22 | 128.00 | 18.90 | 0.85 | - | 7.89 |
| Take Solutions | Neutral | 8.97 | 4.91 | 132.69 | 169.54 | 6.09 | - | - |
| Parnax Lab | Moderately Bearish | 103.00 | -0.48 | 118.30 | 10.30 | 1.43 | - | 31.58 |
| Samrat Pharmachem | Bullish | 356.00 | -1.40 | 110.43 | 15.68 | 1.55 | 0.28 | - |
| Nutricircle | Bearish | 102.00 | -4.98 | 102.00 | 887.92 | 18.51 | - | 13.87 |
Parnax Lab Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Parnax Lab is currently unavailable
Please check back later.
Shareholding Insights
- Pledged found - Promoter(s) have pledged 9.41% of shares.
- Pledging Flat - Promoter(s) pledging has not increased in last quarter.
- Promoter(s) holds a high stake in the company at 72.30%
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Parnax Lab Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-27 | Audited Results |
| 2025-02-10 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| 2024-05-30 | Quarterly Results |
About the company Parnax Lab
- IndustryBiotechnology & Drugs
- ISININE383L01019
- BSE Code506128
- NSE Code
Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.
Parnax Lab Share Price FAQs
Parnax Lab is trading at 103.00 as on Mon Jun 30 2025 09:45:00. This is -0.48% lower as compared to its previous closing price of 103.50.
The market capitalization of Parnax Lab is 118.30 Cr as on Mon Jun 30 2025 09:45:00.
The 52 wk high for Parnax Lab is 193.50 whereas the 52 wk low is 81.00
Parnax Lab can be analyzed on the following key metrics -
- TTM P/E: 10.65
- Sector P/E: 22.85
- Dividend Yield: 0.00%
- D/E ratio: 0.84
Parnax Lab reported a net profit of 11.52 Cr in 2025.
Quick Links